Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 safety study of R(+)Pramipexole for early Alzheimer's disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • R(+) Pramipexole (pramipexole)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-10-12